课题基金 / 基金详情

COVID-19 Variant Network - Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection

COVID-19 Variant Network - Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
COVID-19 变异网络 - 开发 SARS-CoV-2 肽疗法和用于快速病毒检测的护理点唾液诊断
批准号:
443334
负责人:
Babu Mohan
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-02-01 至 2022-02-01

项目摘要

项目成果

Babu Mohan的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SARS-CoV-2 (the causative agent of COVID-19) poses a generational threat, with no licensed vaccines or effective therapies to date. Further, the scarcity in reliable diagnostics, especially when testing asymptomatic/mildly symptomatic cases, is of grave c
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering Mitochondrial Interplay in Bipolar Disorder
  • 批准号:
    469054
  • 项目类别:
    Operating Grants
  • 资助金额:
    $68.55万
  • 财政年份:
    2022
  • 负责人:
    Babu Mohan
  • 依托单位:
COVID-19 Variant Supplement - Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
  • 批准号:
    443198
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Babu Mohan
  • 依托单位:
Development of SARS-CoV-2 Peptide Therapeutics and Point-of-Care Salivary Diagnostics for Rapid Viral Detection
  • 批准号:
    429204
  • 项目类别:
    Operating Grants
  • 资助金额:
    $68.33万
  • 财政年份:
    2020
  • 负责人:
    Babu Mohan
  • 依托单位:
Targeting the Mammalian Mitochondrial Interactome to Dissect Macromolecular Assemblies and Pathways in Health and Disease
  • 批准号:
    354936
  • 项目类别:
    Operating Grants
  • 资助金额:
    $144.06万
  • 财政年份:
    2016
  • 负责人:
    Babu Mohan
  • 依托单位: